Immunotherapy News and Research

Latest Immunotherapy News and Research

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.

13 Jun 2019

Scientists identify potential target for Parkinson's treatment

An international research team led by scientists at the University of Alabama at Birmingham has identified a potential target for therapeutics that might help slow the progression of Parkinson's disease.

12 Jun 2019

Researchers provide insight into unintended consequence of immune checkpoint inhibitors

Immune checkpoint inhibitors are an emerging type of cancer immunotherapy that uses the immune system to attack cancer cells.

12 Jun 2019

The immune system in women may be different from men finds study

Research has shown that women have a different immune system from men and may respond differently to different immune disease processes.

11 Jun 2019

Novel agent shown to have dual mechanism of action to eliminate cancer

Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T Cells to hone in on and eliminate cancer.

11 Jun 2019

Complex molecular conversation is key to the establishment of 'hot tumor'

A Ludwig Cancer Research study has deciphered a complex molecular conversation between cancer and immune cells that is key to orchestrating the successful invasion of tumors by T cells that kill cancer cells.

11 Jun 2019

Drug that targets the immune system can delay type 1 diabetes in high risk children, adults

A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet's Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine.

10 Jun 2019

Researchers propose a new look at the role of ferroptosis in cancer development

Professor of Ghent University and Lead Researcher at the Institute of Biology and Biomedicine of the Lobachevsky University Dmitri Krysko together with scientists from Germany, Professor Marcus Conrad and Professor Jose Pedro Friedmann Angeli recently published an article in the journal Nature Reviews Cancer, one of the highest-rated journals that occupies the 2nd line in the oncology section among 223 journals in this category and has an impact factor of 42.78 according to WoS data.

7 Jun 2019

Three-drug combination could be effective therapy for people with advanced melanoma

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

7 Jun 2019

Promega launches MSI educational website

Researchers and clinicians seeking to deepen their understanding of Microsatellite Instability have a new resource gathering information in one place.

From Promega Corporation 4 Jun 2019

Researchers gain insight into possible origins of 'ancient' immunological memory

Natural killer cells are part of the innate immune system. Their role is to detect virus-infected cells and destroy them.

4 Jun 2019

Researchers develop novel imaging test to predict immunotherapy response in kidney cancer

A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.

4 Jun 2019

Combination immunotherapy shows promise in pre-surgical setting for early-stage lung cancers

Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.

3 Jun 2019

Immunotherapy increases five-year survival rate of patients with advanced non-small cell lung cancer

In a study led by UCLA investigators, treatment with the immunotherapy drug pembrolizumab helped more than 15% of people with advanced non-small cell lung cancer live for at least five years - and 25% of patients whose tumor cells had a specific protein lived at least that long.

3 Jun 2019

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.

31 May 2019

Research reveals immunomodulatory role of ent-kaurane diterpenoids toward NK cells

As early responders in the surveillance of malignant cells, natural killer cells play a significant role in the control of transformed cells at the tumor initiation stage through direct cytolysis. For this reason, NK cell-based immunotherapy is a potential therapeutic strategy for tumor sufferers.

31 May 2019

Immunotherapy News and Research

Latest Immunotherapy News and Research

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

Scientists identify potential target for Parkinson's treatment

Researchers provide insight into unintended consequence of immune checkpoint inhibitors

The immune system in women may be different from men finds study

Novel agent shown to have dual mechanism of action to eliminate cancer

Complex molecular conversation is key to the establishment of 'hot tumor'

Drug that targets the immune system can delay type 1 diabetes in high risk children, adults

Researchers propose a new look at the role of ferroptosis in cancer development

Three-drug combination could be effective therapy for people with advanced melanoma

Promega launches MSI educational website

Researchers gain insight into possible origins of 'ancient' immunological memory

Researchers develop novel imaging test to predict immunotherapy response in kidney cancer

Combination immunotherapy shows promise in pre-surgical setting for early-stage lung cancers

Immunotherapy increases five-year survival rate of patients with advanced non-small cell lung cancer

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

Research reveals immunomodulatory role of ent-kaurane diterpenoids toward NK cells

Mothers can transfer life-long protection against infection to infants by breastfeeding

Cancer researchers discover new functions for common oncogene MYC

Study: Mothers' breast milk can provide protection against infection that lasts for life

Study: Immune discovery may improve cancer therapies

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Immunotherapy News and Research

Latest Immunotherapy News and Research

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in